November 7, 2013: U.S. markets opened roughly flat Thursday morning ignoring decent economic news today on fewer new jobless claims, coupled with a 2.8% GDP growth rate and a cut to the European Central Bank�� key interest rate to obsess over the initial public offering (IPO) of shares in Twitter Inc. (NYSE: TWTR).
European closed mixed today while Latin American and Asian markets closed lower.
Friday�� calendar includes speeches by Fed Chairman Ben Bernanke, Atlanta Fed President Dennis Lockhart, and San Francisco Fed President John Williams, and the following scheduled data releases and events (all times Eastern):
8:30 a.m. – Employment situation 8:30 a.m. – Personal income and outlays 9:55 a.m. – University of Michigan/Reuters consumer confidence index 10:00 a.m. – Job Openings and Labor Turnover Survey (JOLTS)Here are the closing bell levels for Thursday:
S&P500 1747.16 (-23.32; -1.32%) DJIA 15594.87 (-152.07; -0.97%) NASDAQ 3857.33 (-74.61; -1.90%) 10YR TNOTE 2.608% (+0.34375) Gold $1,308.50 (-9.30; -0.7%) WTI Crude oil $94.20 (-0.60; -0.6%) Euro/Dollar: 1.3419 (-0.0095; -0.70%)Big Earnings Movers: SolarCity Corp. (NASDAQ: SCTY) is down 16.7% at $49.71 after providing weak guidance with earnings last night. Qualcomm Inc. (NASDAQ: QCOM) is down 3.7% at $67.15 after a mixed earnings report last night. Whole Foods Market Inc. (NASDAQ: WFM) is down 11.2% at $57.27 as the store tries to shed its luxury image. Himax Technologies Inc. (NASDAQ: HIMX) is down 10.2% at $8.50 on weak guidance.
Best Prefered Companies To Watch For 2015: Pentair Inc.(PNR)
Pentair, Inc. operates as a diversified industrial manufacturing company worldwide. The company?s Water segment offers products and systems for use in the movement, storage, treatment, and enjoyment of water. It offers light duty diaphragm pumps and solid handling pumps for water and wastewater applications and agricultural spraying; and pressure tanks for residential applications. This segment also provides control valves, pressure tanks, membranes, carbon products, point of entry and point of use systems, and other filter cartridges for commercial and residential water filtration applications; and pool equipment and accessories, such as pumps, filters, heaters and heat pumps, lights, automatic controls, automatic pool cleaners, commercial deck equipment, maintenance equipment, and pool accessories for commercial and residential pool maintenance, repair and renovation, and service and construction. In addition, it offers filter systems, filter cartridges, pressure vessels , and dispensing pumps for commercial, foodservice, industrial, marine and aviation markets. This segment distributes its products through wholesale distributors, retail distributors, original equipment manufacturers (OEM), home centers, and home and pool builders. The company?s Technical Products segment provides standard, modified, and custom enclosures that house and protect sensitive electronics and electrical components, as well as protect people that use them. Its products comprise metallic and composite enclosures, cabinets, cases, subracks, backplanes, and associated thermal management systems used in industrial machinery, data communications, networking, telecommunications, test and measurement, automotive, medical, security, defense, and general electronics. This segment distributes its products through electrical and data contractors, electrical and electronic components distributors, and OEMs. Pentair, Inc. was founded in 1966 and is based in Golden Valley, Minne sota.
Advisors' Opinion:- [By The Part-time Investor]
The following stocks met the criteria in January of 2008 and were put into the initial portfolio:
Abbot Labs (ABT)Advanced data processing (ADP)Associated Banc-Corp (ASBC)Bank of America (BAC)BB&T Corp. (BBT)Bemis Company (BMS)Anheuser Busch (BUD)The Chubb Corporation (CB)Clorox (CLX)Comerica Inc. (CMA)Diebold Inc. (DBD)Emerson Electronics (EMR)First Dollar Corp. (FDO)First Third BanCorp. (FITB)Gannett Co, Inc. (GCI)General Electric (GE)Hershey (HSY)Illinois Tools Works (ITW)Johnson and Johnson (JNJ)Leggett and Platt (LEG)Eli Lilly (LLY)La-Z-Boy (LZB)McDonald's (MCD)Marsh and Ilsley (MI)M&T Bancorp (MTB)PepsiCo (PEP)Pfizer (PFE)Procter & Gamble (PG)Pentair Ltd. (PNR)Regions Financial Corp. (RF)Rohm and Haas (ROH)RPM International (RPM)Sherwin Williams (SHW)Sysco Corp. (SYY)UDR Inc. (UDR)Historical quotes were taken from Yahoo Finance. $10,000 was put into each position, to the nearest whole share, so a total of $349,262.89 was invested. From 1/15/08 through 5/16/13 all dividends were reinvested back into the stock that paid them. If a dividend cut was announced, that stock was sold on the ex-div date of the new, lower dividend.
5 Best Asian Stocks To Buy Right Now: Neogenomics Inc (NEO)
NeoGenomics, Inc. (NeoGenomics) operates a network of cancer-focused testing laboratories. The Company offers testing services, including Cytogenetics testing, which is the study of normal and abnormal chromosomes and their relationship to disease; fluorescence in-situ hybridization (FISH) testing, which is a branch of cancer genetics that focuses on detecting and locating the presence or absence of specific deoxyribonucleic acid (DNA) sequences and genes on chromosomes; flow cytometry testing, which is a way to measure the characteristics of cell populations; immunohistochemistry (IHC) testing, this is the process of identifying cell proteins in a tissue section utilizing the principle of antibodies binding specifically to antigens, and molecular testing, which is a cancer diagnostic tool focusing on the analysis of DNA and ribonucleic acid (RNA), as well as the structure and function of genes at a molecular level.
The cancer testing services, that the Company offers to community-based pathologists are designed to be a natural extension of, and complementary to, the services that they perform within their own practices. In areas where the Company does not provide services to community-based pathology practices, it may directly serve oncology, dermatology, urology and other clinician practices that prefer to have a direct relationship with a laboratory for cancer-related genetic and molecular testing services. NeoGenomics services these types of clients with a global service offering where it performs both the technical and professional components of the tests ordered.
The Company offers tech-only flow cytometry and immunohistochemistry testing services. These types of testing services generally allow the professional interpretation component of a test to be billed separately from the technical component. Its NeoFISH, NeoFLOW and other tech-only service offerings allow properly trained and credentialed community-based pathologists to extend their own practices by performing ! professional interpretations services.
The Company's tech-only services are designed to give pathologists the option to choose, on a case by case basis, whether they want to order just the technical information and images relating to a specific test so they can perform the professional interpretation, or order global services and receive a test report, which includes a NeoGenomics Pathologist�� interpretation of the test results.
The Company also offers a set of global services to meet the needs of those clients who are not credentialed and trained in interpreting genetic tests and who are looking for specialists to interpret the testing results for them. In its global service offerings, its lab performs the technical component of the tests and its doctor of medicine (M.D.s) and doctor of philosophy (Ph.D) s to provide the interpretation services. Its genetic pathology solutions (GPS) report summarizes all relevant case data from its global services on one summary report.
The Company competes with General Electric Healthcare Services and Novartis, A.G.
Advisors' Opinion:- [By John Udovich]
One way or the other, Merrimack Pharmaceuticals Inc (NASDAQ: MACK), Covidien plc (NYSE: COV), NeoGenomics, Inc (NASDAQ: NEO) and�CollabRx Inc (NASDAQ: CLRX) are targeting Barrett's Esophagus�or�esophageal cancer�(the former often leads to the latter) ��a form of cancer that may not be on the top of your list of cancers but is nevertheless on the rise. Approximately 3 million Americans suffer from Barrett's Esophagus, �a condition that�develops as a result of chronic injury from gastroesophageal reflux disease (GERD) where the�normal esophageal lining is replaced with abnormal cells (known as Barrett�� tissue), putting patients at greater risk of developing cancer of the esophagus. And although less than 1% of these patients develop cancer each year, esophageal carcinoma is frequently not detected until later stages, at which point therapy options are limited, extremely invasive, and often ineffective.�This means that�early detection is important�along with�regular surveillance is recommended.�
5 Best Asian Stocks To Buy Right Now: Opt-Sciences Corp (OPST)
Opt-Sciences Corporation, incorporated on November 1956, conducts its business through its wholly owned subsidiary, O and S Research, Inc. The Company deposits anti-glare and/or transparent conductive optical coatings on glass used primarily to cover instrument panels in aircraft cockpits. It also provides full glass cutting, grinding and painting operations, which augment its optical coating capabilities. Its products are designed to enable pilots to read aircraft instruments in direct sunlight or at night or in covert situations using appropriate night vision filters or to protect the instruments from electromagnetic interference. The Company�� business is dependent on a robust commercial, business, and regional aircraft market and to a lesser degree the military aircraft market. It generally has a four to twelve week delivery cycle depending on product complexity, available plant capacity and required lead time for specialty raw materials, such as polarizers or filter glass.
The Company�� offers incorporate an optical coating of some type. Its primary coatings are for aircraft cockpit display applications and consist of its anti-reflection coating used for glare reduction and its transparent conductive coating used for electromagnetic interference shielding. In addition, it also offers a full range of other specialty instrument glass, including night vision filter glass, circular polarizers, touchpads, glass sandwiches for liquid crystal displays (LCDs) as well as other custom designed specialty glass components and assemblies. It uses its technology to apply a micro thin optical non-glare and/or conductive coating to the glass. Both processes utilize the deposit of a thin film of metal or metal oxide on the surface of the glass. The process takes place in a heated vacuum chamber. It heats the deposited material to over 1800 degrees Centigrade causing it to evaporate.
The Company competes with JDSU, Mod A Can, Dontech, Schott Glass and Hoya Optics
Advisors' Opinion:- [By Geoff Gannon] ng>Micropac
Micropac is 76% owned by Heinz-Werner Hempel. He�� a German businessman. You can see the German company he founded here. He�� had control of Micropac for a long-time. I don�� have an exact number in front of me. But I would guess it�� been something like 25 years.
ADDvantage
ADDvantage Technologies is controlled by the Chymiak brothers. See the company�� April 4 press release explaining their decision to turn over the CEO position to an outsider. Regardless, the Chymiaks still control 47% of the company. Ken Chymiak is now chairman. And David Chymiak is still a director and now the company�� chief technology officer. Clearly, it�� still their company.
By the way, the name ADDvantage Technologies has nothing to do with the Chymiaks. Today�� AEY really traces its roots to a private company called Tulsat. The Chymiak brothers acquired that company about 27 years ago. So, effectively, when you buy shares of AEY you are buying into a 27-year-old family-controlled company.
That�� pretty typical in the world of net-nets.
Solitron
Solitron Devices is 29% owned by Shevach Saraf. He has been the CEO for 20 years. The post-bankruptcy Solitron has never known another CEO. Before the bankruptcy, Solitron was a much bigger, much different company. So even though we are not talking about the founder here ��and even though 70% of the company�� shares are not held by the CEO ��we��e still talking about a company where one person has a lot of control. Solitron only has three directors. Saraf is the chairman, CEO, president, CFO and treasurer. Neither of the other two directors joined the board within the last 15 years. So, we aren�� talking about a lot of tumult at the top.
In fact, profitable net-nets seem to be especially common candidates for abandoning the responsibilities of a public company without actually getting taken private.
OPT-Sciences
This company is controlled by Arthu
5 Best Asian Stocks To Buy Right Now: Light SA (LIGT3)
Light SA, formerly TRIAL Participacoes SA, is a Brazil-based holding company primarily involved in the energy sector. Light SA is a parent of the Light Group. The Company operates through four segments, such as Power Distribution, Power Generation, Power Trading and Others, through which the Company is engaged in the generation, transmission, distribution and marketing of electric power and other related services. The Company distributes energy to approximately 31 municipalities in the state of Rio de Janeiro. Additionally, the Company is engaged in the manufacture of two-wheeled electric vehicles. The Company operates through subsidiaries, such as Light Servicos de Eletricidade SA, CR Zongshen E Power Fabricadora de Veiculos SA, Light Energia SA, Lightger SA, Itaocara Energia Ltda, Amazonia Energia SA, Light Esco Prestacaoo de Servicos SA, Lightcom Comercializadora de Energia SA, Light Solucoes em Eletricidade Ltda, Axxiom Solucoes Tecnologicas SA and Instituto Light. Advisors' Opinion:- [By Ney Hayashi]
Oil company Petroleo Brasileiro SA (PETR4) contributed the most to the gauge�� advance as crude climbed. BR Properties SA rose the most since July 2012 after saying it will buy back shares. Phone company Tim Participacoes SA rebounded from a five-week low. Power utility Light SA (LIGT3) rallied after posting third-quarter earnings that beat analysts��estimates.
No comments:
Post a Comment